Get started
Author

Gerasimos J. Mantzaris

Observed names: G J Mantzaris, G. J. Mantzaris, G.J. Mantzaris, Gerasimos J Mantzaris
OpenAlex ID: A5103800245
Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting
2020 · David T. Rubin, Maria T. Abreu, et al. · Gastroenterology · 193
PDF
DNA methylation changes in inflammatory bowel disease.
2014 · Pantelis S Karatzas, Maria Gazouli, et al. · Europe PMC (PubMed Central) · 61
De-escalation of Infliximab Maintenance Therapy from 8- to 10-week Dosing Interval Based on Faecal Calprotectin in Patients with Crohn’s Disease
2015 · Konstantinos Papamichael, Pantelis Karatzas, et al. · Journal of Crohn s and Colitis · 19
Simethicone adjunct to polyethylene glycol improves small bowel capsule endoscopy imaging in non-Crohn's disease patients.
2015 · Konstantinos Papamichael, Pantelis Karatzas, et al. · PubMed Central · 15
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece
2019 · Nikos Viazis, Christos Pontas, et al. · European Journal of Gastroenterology & Hepatology · 12
Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification
2017 · Athanasios Tsigaridas, Athanassios K. Anagnostopoulos, et al. · Journal of Proteomics · 12
Predictors of tissue healing in ulcerative colitis patients treated with anti-TNF
2016 · Nikos Viazis, Marios Giakoumis, et al. · Digestive and Liver Disease · 9
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD
2021 · Giorgos Bamias, Georgios Kokkotis, et al. · European Journal of Gastroenterology & Hepatology · 8
Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain
2017 · Nikos Viazis, Konstantina Katopodi, et al. · European Journal of Gastroenterology & Hepatology · 6
Proteomics and irritable bowel syndrome
2017 · Athanasios Tsigaridas, Ioannis S. Papanikolaou, et al. · Expert Review of Proteomics · 5
16 Relationships between clinical remission, C-reactive protein normalization and mucosal healing in Crohn's disease: analyses from the SONIC trial
2013 · L. Peyrin-Biroulet, W. Reinisch, et al. · Journal of Crohn s and Colitis · 5
The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
2023 · N. Viazis, I. Drygiannakis, et al. · Digestive and Liver Disease · 4
PDF
Helicobacter pylori and colorectal cancer: Is there any link?
2007 · Gerasimos J. Mantzaris · Annals of Gastroenterology · 4
Anal defecatory function in ulcerative colitis patients after total proctocolectomy and ileal pouch-anal anastomosis: a prospective cohort study
2023 · Nikos Viazis, Anastasios Manolakis, et al. · European Journal of Gastroenterology & Hepatology · 3
Dietary Interventions With Solid Foods in Adults With Crohn Disease: Methodological Insights From a Scoping Review
2025 · Konstantina Morogianni, Dimitrios Karayiannis, et al. · Nutrition Reviews · 1
P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry
2022 · E Zacharopoulou, E Orfanoudaki, et al. · Journal of Crohn s and Colitis · 1
Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission
2021 · N Viazis, C Pontas, et al. · Acta gastro-enterologica belgica · 1
PDF
DOP79 Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series
2021 · A Albshesh, P Eder, et al. · Journal of Crohn s and Colitis · 1
PDF
P387 Real-world clinical outcomes of biologic-naïve non-complicated Crohn’s disease patients treated with vedolizumab: Results from the EVOLVE study
2020 · A Yarur, G J Mantzaris, et al. · Journal of Crohn s and Colitis · 1
PDF
P659 Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission
2019 · N Viazis, C Pontas, et al. · Journal of Crohn s and Colitis · 1
Is the activity and severity of gastritis and Helicobacter pylori load related to the outcome of anti-H. pylori treatment?
1998 · G.J. Mantzaris, Em. Archavlis, et al. · Gastroenterology · 1
Beyond the “ideal” candidate: The Crohn's disease exclusion diet's potential in perianal disease - a case report
2025 · Konstantina Morogianni, Aikaterini Mountaki, et al. · Clinical Nutrition ESPEN
PDF
P668 Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease
2022 · E Orfanoudaki, E Zacharopoulou, et al. · Journal of Crohn s and Colitis
Efficacy of Infliximab after Failure of Subcutaneous Anti-TNF Agents in Patients with Moderate to Severe Ulcerative Colitis
2020 · Nikos Viazis, C Pontas, et al. · Hospital chronicles/Hospital Chronicles
PDF
P296 Levels of engagement in physical activity and fatigue in IBD patients
2018 · K Gatt, J Schembri, et al. · Journal of Crohn s and Colitis
Works count: 32
Citation count: 365
H-index: 8
I10-index: 6
Year
Topic
Type